Connect with us

Published

on

The logos of Google, Apple, Facebook, Amazon and Microsoft displayed on a mobile phone with an EU flag shown in the background.

Justin Tallis | AFP via Getty Images

A raft of major technology and media companies have signed an open letter accusing tech giants of failing to bring their businesses into full compliance with incoming European Union digital competition rules.

The signatories say that companies defined by the EU as “gatekeepers,” including Google, Amazon, Apple, Meta, Microsoft, and TikTok owner ByteDance, haven’t done enough to engage effectively with them and others in their industry.

Under the EU’s Digital Markets Act, companies with more than 45 million monthly active users and a market capitalization over 75 billion euros ($81.2 billion) are considered gatekeepers.

They are required to, for example, make their messaging apps work with those of rivals, and let users decide which apps come pre-installed with their devices.

Another EU requirement is that these platforms do not implement practices that lead to the “self-preferencing” of their services over others.

The open letter, which was signed by international media group Schibsted, eco-friendly search engine Ecosia, privacy-focused search engine Qwant, secure messaging app Element, and VPN service ProtonVPN, said the gatekeepers “have either failed to engage in a dialogue with third parties or have presented solutions falling short of compliance with the DMA.”

They also said that businesses and consumers have been largely “kept in the dark” about what’s going to happen after March 7, 2024 — a pivotal deadline by which all six Big Tech gatekeepers need to get their businesses into compliance with the DMA.

Regulatory risk to U.S. tech giants on market monopoly is real, but not priced in yet

“The signatories of this letter represent thousands of businesses affected by the DMA,” the letter stated. “They urge the gatekeepers to engage as soon as possible with business users and other stakeholders, such as business and consumer associations, in a constructive dialogue and make swift progress on their proposed compliance solutions.”

“They also urge the European Commission and the European Parliament to use all within their power to ensure that the gatekeepers comply with both the letter and spirit of the DMA, starting from 7 March 2024,” the signatories added.

Here are the 24 companies that signed the letter:

  • Adevinta
  • Allegro
  • Billiger.de
  • Ceneo
  • CompareGroup
  • Ecosia
  • Element
  • Favi
  • Heureka Group
  • Idealo
  • Kelkoo
  • Ladenzeile
  • Le Guide.com
  • OLX
  • Open-Xchange
  • Panther Holding GmbH
  • Preis.de
  • Prisjakt
  • Proton
  • Qwant
  • Runnea
  • Schibsted
  • Solute
  • Vipps

The EU Commission and the EU Parliament were not immediately available for comment on the issue when contacted by CNBC. CNBC also reached out to Google-parent Alphabet, Amazon, Apple, Meta, Microsoft, and ByteDance.

Christian Kroll, CEO and co-founder of Ecosia, told CNBC ahead of the open letter that regulators needed to keep large technology companies in check, or else risk businesses like his facing financial consequences.

“There has always been a huge challenge: Google has had the monopoly for over a decade, but I think we are currently more optimistic than that. It is yet to be determined what will happen on March 7 but we know that 2024 must be the year of fair choice in online search for Europe,” Klein told CNBC.

“EU policy makers have the choice to deliver a digital market that delivers fair competition and choice for European consumers and business,” Kroll added.

Of particular issue for Ecosia and other competing search engines was a proposal from Google for a “choice screen” that would display different search engines on the same window.

“Without a choice screen that is designed fairly, in the letter and spirit of the DMA, we will not see a positive shift in market share but rather further entrenchment of the dominance of gatekeepers such as Google – which would be a failure of the DMA,” Kroll added.

“Ahead of the March 2024 deadline, we need support from the EC and all hands on deck to ensure proactive engagement. The focus of digital regulators around the world will be on Europe as global interest in choice screens increases.”

Last week, the EU Commissioner for Competition Margrethe Vestager met with the CEOs of Apple, Alphabet, and Qualcomm to discuss regulation and competition policy compliance, according to a post by Vestager on X.

She said she had discussed Apple’s obligation to allow distribution of its apps outside the company’s proprietary AppStore, as well as ongoing competition cases including one involving the firm’s Apple Music music streaming platform.

With Google CEO Sundar Pichai, Vestager said she discussed the design of choice screens, self-preferencing requirements under the DMA, and an EU antitrust case looking at the company’s role in the advertising technology market.

She didn’t specify what was discussed with Qualcomm CEO Cristiano Amon.

Continue Reading

Technology

Whoop says FDA is ‘overstepping its authority’ with warning about blood pressure feature

Published

on

By

Whoop says FDA is 'overstepping its authority' with warning about blood pressure feature

The logo for the Food and Drug Administration is seen ahead of a news conference on removing synthetic dyes from America’s food supply, at the Health and Human Services Headquarters in Washington, DC on April 22, 2025.

Nathan Posner | Anadolu | Getty Images

The U.S. Food and Drug Administration on Tuesday published a warning letter addressed to the wrist wearable company Whoop, alleging it is marketing a new blood pressure feature without proper approvals.

The letter centers around Whoop’s Blood Pressure Insights (BPI) feature, which the company introduced alongside its latest hardware launch in May.

Whoop said its BPI feature uses blood pressure information to offer performance and wellness insights that inform consumers and improve athletic performance.

But the FDA said Tuesday that Whoop’s BPI feature is intended to diagnose, cure, treat or prevent disease — a key distinction that would reclassify the wellness tracker as a “medical device” that has to undergo a rigorous testing and approval processes.

“Providing blood pressure estimation is not a low-risk function,” the FDA said in the letter. “An erroneously low or high blood pressure reading can have significant consequences for the user.”

A Whoop spokesperson said the company’s system offers only a single daily estimated range and midpoint, which distinguishes it from medical blood pressure devices used for diagnosis or management of high blood pressure.

Whoop users who purchase the $359 “Whoop Life” subscription tier can use the BPI feature to get daily insights about their blood pressure, including estimated systolic and diastolic ranges, according to the company.

Whoop also requires users to log three traditional cuff-readings to act as a baseline in order to unlock the BPI feature.

Additionally, the spokesperson said the BPI data is not unlike other wellness metrics that the company deals with. Just as heart rate variability and respiratory rate can have medical uses, the spokesperson said, they are permitted in a wellness context too.

“We believe the agency is overstepping its authority in this case by attempting to regulate a non-medical wellness feature as a medical device,” the Whoop spokesperson said.

Read more CNBC tech news

High blood pressure, also called hypertension, is the number one risk factor for heart attacks, strokes and other types of cardiovascular disease, according to Dr. Ian Kronish, an internist and co-director of Columbia University’s Hypertension Center.

Kronish told CNBC that wearables like Whoop are a big emerging topic of conversation among hypertension experts, in part because there’s “concern that these devices are not yet proven to be accurate.”

If patients don’t get accurate blood pressure readings, they can’t make informed decisions about the care they need.

At the same time, Kronish said wearables like Whoop present a “big opportunity” for patients to take more control over their health, and that many professionals are excited to work with these tools.

Understandably, it can be confusing for consumers to navigate. Kronish encouraged patients to talk with their doctor about how they should use wearables like Whoop.

“It’s really great to hear that the FDA is getting more involved around informing consumers,” Kronish said.

FILE PHOTO: The headquarters of the U.S. Food and Drug Administration (FDA) is seen in Silver Spring, Maryland November 4, 2009. 

Jason Reed | Reuters

Whoop is not the only wearable manufacturer that’s exploring blood pressure monitoring.

Omron and Garmin both offer medical blood pressure monitoring with on-demand readings that fall under FDA regulation. Samsung also offers blood-pressure-reading technology, but it is not available in the U.S. market.

Apple has also been teasing a blood pressure sensor for its watches, but has not been able to deliver. In 2024, the tech giant received FDA approval for its sleep apnea detection feature.

Whoop has previously received FDA clearance for its ECG feature, which is used to record and analyze a heart’s electrical activity to detect potential irregularities in rhythm. But when it comes to blood pressure, Whoop believes the FDA’s perspective is antiquated.

“We do not believe blood pressure should be considered any more or less sensitive than other physiological metrics like heart rate and respiratory rate,” a spokesperson said. “It appears that the FDA’s concerns may stem from outdated assumptions about blood pressure being strictly a clinical domain and inherently associated with a medical diagnosis.”

The FDA said Whoop could be subject to regulatory actions like seizure, injunction, and civil money penalties if it fails to address the violations that the agency identified in its letter.

Whoop has 15 business days to respond with steps the company has taken to address the violations, as well as how it will prevent similar issues from happening again.

“Even accounting for BPI’s disclaimers, they do not change this conclusion, because they are insufficient to outweigh the fact that the product is, by design, intended to provide a blood pressure estimation that is inherently associated with the diagnosis of a disease or condition,” the FDA said.

WATCH: Watch CNBC’s full interview with FDA commissioner Dr. Marty Makary

Watch CNBC's full interview with FDA commissioner Dr. Marty Makary

Continue Reading

Technology

Amazon turns to rival SpaceX to launch next batch of Kuiper internet satellites

Published

on

By

Amazon turns to rival SpaceX to launch next batch of Kuiper internet satellites

United Launch Alliance Atlas V rocket carrying the first two demonstration satellites for Amazon’s Project Kuiper broadband internet constellation stands ready for launch on pad 41 at Cape Canaveral Space Force Station on October 5, 2023 in Cape Canaveral, Florida, United States.

Paul Hennessey | Anadolu Agency | Getty Images

As Amazon chases SpaceX in the internet satellite market, the e-commerce and computing giant is now counting on Elon Musk’s rival company to get its next batch of devices into space.

On Wednesday, weather permitting, 24 Kuiper satellites will hitch a ride on one of SpaceX’s Falcon 9 rockets from a launchpad on Florida’s Space Coast. A 27-minute launch window for the mission, dubbed “KF-01,” opens at 2:18 a.m. ET.

The launch will be livestreamed on X, the social media platform also owned by Musk.

The mission marks an unusual alliance. SpaceX’s Starlink is currently the dominant provider of low earth orbit satellite internet, with a constellation of roughly 8,000 satellites and about 5 million customers worldwide.

Amazon launched Project Kuiper in 2019 with an aim to provide broadband internet from a constellation of more than 3,000 satellites. The company is working under a tight deadline imposed by the Federal Communications Commission that requires it to have about 1,600 satellites in orbit by the end of July 2026.

Amazon’s first two Kuiper launches came in April and June, sending 27 satellites each time aboard rockets supplied by United Launch Alliance.

Assuming Wednesday’s launch is a success, Amazon will have a total of 78 satellites in orbit. In order to meet the FCC’s tight deadline, Amazon needs to rapidly manufacture and deploy satellites, securing a hefty amount of capacity from rocket providers. Kuiper has booked up to 83 launches, including three rides with SpaceX.

Space has emerged as a battleground between Musk and Amazon founder Jeff Bezos, two of the world’s richest men. Aside from Kuiper, Bezos also competes with Musk via his rocket company Blue Origin.

Blue Origin in January sent up its massive New Glenn rocket for the first time, which is intended to rival SpaceX’s reusable Falcon 9 rockets. While Blue Origin currently trails SpaceX, Bezos last year predicted his latest venture will one day be bigger than Amazon, which he started in 1994.

Kuiper has become one of Amazon’s biggest bets, with more than $10 billion earmarked for the project. The company may need to spend as much as $23 billion to build its full constellation, analysts at Bank of America wrote in a note to clients last week. That figure doesn’t include the cost of building terminals, which consumers will use to connect to the service.

The analysts estimate Amazon is spending $150 million per launch this year, while satellite production costs are projected to total $1.1 billion by the fourth quarter.

Amazon is going after a market that’s expected to grow to at least $40 billion by 2030, the analysts wrote, citing estimates by Boston Consulting Group. The firm estimated that Amazon could generate $7.1 billion in sales from Kuiper by 2032 if it claims 30% of the market.

“With Starlink’s solid early growth, our estimates could be conservative,” the analysts wrote.

WATCH: Amazon launches first Kuiper internet satellites into space

Amazon launches first Kuiper internet satellites into space

Continue Reading

Technology

Bitcoin falls below $117,000 after Trump crypto bills are blocked before vote

Published

on

By

Bitcoin falls below 7,000 after Trump crypto bills are blocked before vote

Bitcoin falls as lawmakers grapple with crypto regulation bills: CNBC Crypto World

Bitcoin fell below the $117,000 level on Tuesday after cryptocurrency-related bills were blocked in the House of Representatives.

The price of bitcoin was last down 2.8% at $116,516.00, according to Coin Metrics. That marks a pullback from the day’s high of $120,481.86.

Stock Chart IconStock chart icon

hide content

Bitcoin/USD Coin Metrics, 1-day

The drop comes on the heels of multiple crypto-related bills failing to overcome a procedural hurdle in the House, with 13 Republicans voting with Democrats to block the motion in a 196-223 vote.

In recent days, bitcoin has been trading at all-time highs, spurred by institutional buying of bitcoin exchange-traded funds (ETFs) amid rising optimism that Congress would soon pass crypto legislation.

Stocks linked to crypto also came under pressure in late afternoon trading. Shares of bitcoin miners Riot Platforms and Mara Holdings closed down 3.3% and 2.3%, respectively. Others like crypto trading platforms Coinbase slid 1.5%. All were under pressure in extended trading.

Continue Reading

Trending